344 Followers on Owler

Kymera

is a Massachusetts-based biopharmaceutical company that develops targeted protein degradation therapies for the treatment of cancer and inflammatory diseases... Read more
OverviewCompetitorsFundingNews & Insights

Kymera

is a Massachusetts-based biopharmaceutical company that develops targeted protein degradation therapies for the treatment of cancer and inflammatory diseases... Read more
Kymera President & CEO: Nello Mainolfi

President & CEO

Nello Mainolfi

CEO Approval Rating

88/100

2015

PublicIndependent CompanyNASDAQKYMR

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
$47.1M
Employees
170
Funding
$1.1B

News

Funding
Aug 21, 2024
GlobeNewswire
Kymera received $225M in Post-IPO Equity Funding

Kymera Competitors

1C4T
2Nurix
3Arvinas
4Foghorn Therapeutics
5Vividion
6Cullgen
7Cedilla
8Jounce
9SiteOne
10NexImmune
Unlock 8 + competitors

Trending Companies